News Focus
News Focus
icon url

mike_dotcom

12/19/22 8:08 AM

#393326 RE: LBSR TO DA MOON #393324

Wow, they are going to triple their market cap based on "potentially clinically meaningful effects ." Must be nice indeed. I guess their methods or conclusions haven't been attacked - yet.
icon url

JKS3

12/19/22 8:19 AM

#393328 RE: LBSR TO DA MOON #393324

That's what happens when an honest company announces positive results with REAL endpoints.
icon url

tredenwater2

12/19/22 11:14 AM

#393377 RE: LBSR TO DA MOON #393324

Madrigal Pharmaceuticals Shares Rise Almost 200% After Company Announced Resmetirom Achieved Both Primary Endpoints in NASH and Liver Fibrosis Trial
BENZINGA 7:13 AM ET 12/19/2022



What was their price they sprung up from? 1 yr, 2yr, 3yr high? Nope, just the opposite, almost a 3 yr low.